In the past 10 years Campylobacter jejuni has been recognized as a major cause of diarrheal disease in many countries. The illness, which consists of diarrhea (frequently bloody) and severe abdominal cramping, affects all age groups. C. jejuni has been implicated in a number of outbreaks investigated by the Centers for Disease Control since 1978 (5-7, 18, 23) . Although numerous outbreaks have been described in the literature, the modes and vehicles of transmission are not well defined. One reason for the limited knowledge in this area is the lack of a widely available typing system for C. jejuni. Although several serotyping methods have been described, no single method has been widely accepted (1, (12) (13) (14) . Until a satisfactory serotying system becomes available for many laboratories, other typing methods are needed for epidemiological purposes.
Since C. jejuni strains have been reported to be resistant to a variety of antimicrobial agents (10, 11, 15, 16, (20) (21) (22) 24) and to possess plasmid DNA (2, 8, 17, 19) , this study evaluated the usefulness of these characteristics as epidemiological markers. In addition, the study strains were serotyped by the methods of Penner and Hennessy (14) and Lior et al. (13) .
MATERIALS AND METHODS
Bacterial strains. A total of 31 strains of C. jejuni from 11 different outbreaks of diarrheal illness in the United States were included in this study. Of these, 31 strains were isolated from humans, and 1 was isolated from a cow (Table 1) . Cultures were stored at -70°C until tested.
MICs. MICs were determined by standard methods for agar-dilution tests in Mueller-Hinton agar (Difco Laboratories, Detroit, Mich.) with 5% sheep blood. After inoculation, plates were incubated at 37°C in 5% 02-10% CO-85% N2 for 48 h.
Twofold serial dilutions of antimicrobial stock solutions were prepared so that concentrations of antimicrobial agents ranged from 0.25 ,ug/ml to 128 ,ug/ml. The (4) . Growth from blood-agar plates was suspended in 0.5 ml of buffer before treatment with lysozyme and detergent, alkaline denaturation, and ethanol precipitation. The partially purified plasmid DNA was further treated with RNase, and protein was extracted with phenol-chloroform before a second ethanol precipitation. This purified preparation was electrophoresed for 3 h at 70 mA on a 0.85% vertical agarose gel in a Tris-acetate buffer (40 mM Tris, 40 mM sodium acetate, 2 mM sodium-EDTA [pH 8.2]) system. Gels were stained with ethidium bromide and photographed under UV light. One strain of Escherichia coli (V517) containing plasmids of known molecular weights was routinely included on each gel.
The purified plasmid DNA from selected C. jejuni strains was further analyzed by restriction endonuclease digestion, using the enzyme HindIII (Bethesda Research Laboratories, Inc., Gaithersburg, Md.) according to the manufacturer's suggestions. The resulting digest was electrophoresed as described above in a 1% agarose gel. Lambda phage DNA was included in each experiment as a control for complete enzymatic digestion and as molecular weight standards for DNA fragments.
Serotyping. Serotyping of C. jejuni isolates was performed as described elsewhere by Penner and Hennessy (14) and Lior et al. (13) . The serotyping system described by Lior et al. contains absorbed antisera for detection of heat-labile antigens by slide agglutination of live cells. The method of Penner and Hennessy is an indirect hemagglutination technique for heat-stable antigens of C. jejuni.
RESULTS
MICs. All strains were sensitive to clindamycin, erythromycin, gentamicin, kanamycin, streptomycin, and tobramycin (Table 2) . Chloramphenicol inhibited the majority of strains at 8 ,ug/ml, but 16 FLg/ml was required to inhibit two strains. Of 31 strains, 5 were resistant to ampicillin (MIC 32 lig/ml), 5 strains were resistant to carbenicillin (MIC 128 ,utg/ml), 6 strains were resistant to metronidazole (MIC2 32 ,ug/ml), and 13 strains were resistant to tetracycline (MIC 2 32 ,ug/ml).
Tetracycline-resistant strains were isolated from patients in 4 of the 11 outbreaks studied (Table 3) . These outbreaks were from widely separated areas of the United States (Connecticut, Illinois, Arizona, and California) and occurred over a 2-year period.
Plasmid analysis. Of the 31 C. jejuni (representing eight outbreaks) strains examined, 19 contained plasmid DNA (Table 3 ). The 13 isolates that were resistant to tetracycline contained a 38-megadalton (Mdal) plasmid (approximate molecular mass) (Fig. 1) , but no other antimicrobial resistance was associated with the presence of plasmid DNA. HindIII digestion of the 38-megadalton (Mdal) plasmid from three of these strains yielded fragment-banding patterns that were essentially identical (Fig. 2) . HindIII digestion of 
DISCUSSION
Resistance to erythromycin and tetracycline is not uncommon in C. jejuni; in one study 26% of the strains tested were resistant to tetracycline (16) . In addition, strains of C. jejuni ; E, A5600 (outbreak 9); F, molecular weight standard; G, A6570 (outbreak 11); H, A6571 (outbreak 11); I, A6578 (outbreak 11); J, sporadic isolate of tetracycline-resistant C. jejuni.
All tetracycline-resistant strains examined contained a 38-Mdal plasmid.
have been reported to be resistant to ampicillin, carbenicillin, chloramphenicol, clindamycin, gentamicin, tobramycin, streptomycin, and metronidazole (10, 11, 15, 16, (20) (21) (22) 24) . In this study, isolates from 9 of 11 outbreaks were resistant to one or two of the following antimicrobial agents: ampicillin, carbenicillin, metronidazole, and tetracycline. No isolate was resistant to more than two antimicrobial agents. A third of the outbreaks studied were associated with tetracycline-resistant C. jejuni.
The fact that the C. jejuni strains tested were susceptible to most of the antimicrobial agents limited the usefulness of antimicrobial resistance as an epidemiological marker. Perhaps the addition of other antimicrobial agents would enhance this method. Antimicrobial susceptibility testing by an agar MIC procedure is time consuming, particularly for C. susceptibility testing for C. jejuni and would provide fairly rapid results. This method is probably the most feasible procedure for most laboratories at this time.
Plasmids were present in isolates from 8 of the 11 outbreaks. Other investigators have not found as high an incidence of plasmid DNA in C. jejuni as was found in this study (2, 3, 8) . If most C. jejuni strains do not possess plasmid DNA, plasmid analysis would be of little value in discriminating epidemic strains. However, plasmid profiles are relatively rapid procedures and can provide quick preliminary information for outbreak investigations. As in previous studies, tetracycline resistance was always associated with a 38-Mdal plasmid (17, 19) . The 38-Mdal plasmids from different tetracycline-resistant strains in this study showed essentially identical fragment-banding patterns after HindIII digestion.
Serotype by both methods, antimicrobial susceptibility, and plasmid profile correlated well for 7 of the 11 outbreaks. Data from outbreaks 4 through 7 do not show this correlation. In strains from outbreaks 6 and 7, there is some disagreement between the two serotyping methods. In outbreaks 4 and 5, the strains are the same serotype, but in each case one strain possessed plasmid DNA and was resistant to one or two antimicrobial agents, whereas the other strain lacked both characteristics.
Serotyping is of obvious value in investigations of C.
jejuni epidemics, but is only performed in a few laboratories in the United States. In our investigation all of the strains were typable by the system of Penner and Hennessy and all but three were typable by the system of Lior et al. Serotyping is the method of choice for investigation of outbreaks, but when not available, either plasmid profiles or antibiotic susceptibility patterns may be useful. A combination of two of these methods would provide more useful information than any single method.
